Datavault AI Inc. (NASDAQ:DVLT) is one of the best penny stocks under $1 to buy right now. On February 23, Datavault AI and Wellgistics Health Inc. (NASDAQ:WGRX) announced an expansion of their partnership to develop a Healthcare-as-a-Service/HaaS model powered by blockchain-enabled smart contracts. This initiative builds on their existing PharmacyChain technology, which currently digitizes the tracking of prescription drugs from script to fulfillment. The expanded collaboration will integrate Datavault ...

Previously announced partnership with Tollo Health subsidiary TolloCare adding telehealth service offering to drive Wellgistics Pharmacy prescription drug dispending of GLP-1 drugs and promote patient engagement via mental health AI software solution for compliance and to promote lifestyle changes TAMPA, FL / ACCESS Newswire / February 18, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (' ...

Core Insights - The article discusses the strategic partnership between Wellgistics Health, Inc. and DataVault AI, Inc. to enhance the PharmacyChain platform using advanced technologies [1] - The partnership aims to leverage DataVault AI's edge network and quantum key encryption to improve data-driven outcomes in the $634 billion prescription drug market [1] Company Overview - Wellgistics Health, Inc. is a leader in health information technology, focusing on pharmacy dispensing optimization through its AI platform EinsteinRx [1] - DataVault AI, Inc. specializes in AI-driven data valuation, monetization, and secure tokenization within Web 3.0 environments [1] Technology Integration - The partnership will integrate DataVault AI's advanced technology platform into Wellgistics' PharmacyChain, enhancing its blockchain-enabled smart contracts and tokenization capabilities [1] - Quantum key encryption will fortify pharmacies against potential threats from quantum computing, which could compromise traditional encryption methods [1]

Core Insights - Wellgistics Health, Inc. is integrating its AI platform EinsteinRx into pharmacy point-of-sales systems to enhance prescription drug dispensing efficiency [1] - The company aims to onboard up to 500 pharmacies per month into the Wellgistics Pharmacy Network by the end of 2026 [1] - The focus of the manufacturer-supplier relationship expansion is on diabetes, weight loss, cardiometabolic, and Long COVID patients [1] - Wellgistics is assessing resources for the development of blockchain-enabled smart contracts through its PharmacyChain platform [1] - The company is entering a phase of hyper-focused operational execution under the leadership of President and Interim-CEO Prashant Patel [1]

Core Viewpoint - Wellgistics Health, Inc. is integrating its proprietary AI platform EinsteinRx into its blockchain-enabled smart contracts platform PharmacyChain, enhancing its position in health information technology [1] Group 1: Company Overview - Wellgistics Health, Inc. is a leader in health information technology [1] - The company is publicly traded on NASDAQ under the ticker symbol WGRX [1] Group 2: Product Integration - Wellgistics is combining its AI-driven pharmacy dispensing optimization platform EinsteinRx with its PharmacyChain platform [1] - This integration aims to improve efficiency and effectiveness in pharmacy operations [1] Group 3: Shareholder Information - The company has announced a record date of December 19, 2025, for shareholders to receive Dream Bowl 2026 Meme Coin tokens [1] - Eligible shareholders will receive one Dream Bowl token for each share of common stock owned [1]

Core Insights - Wellgistics Health, Inc. has launched the diabetes prescription drug Brenzavvy® targeting 33 million Americans diagnosed with type II diabetes, primarily through its network of 6,500 independent pharmacies [1][4] - The SGLT-2 inhibitor market, which includes drugs like Jardiance®, reached sales of $16.8 billion in 2024 and is projected to grow to $28.9 billion by 2033, with the U.S. accounting for 40.8% of this market [2][4] - The proprietary EinsteinRx™ artificial intelligence platform will assist pharmacists in optimizing therapy selection and educating providers about Brenzavvy's benefits compared to other SGLT-2 inhibitors [2][3] Company Overview - Wellgistics Health integrates its EinsteinRx™ AI platform with a blockchain-enabled smart contracts platform, PharmacyChain™, to enhance the prescription drug dispensing process [4][5] - The company aims to improve patient access to medications while providing revenue opportunities for pharmacists through patient education on Brenzavvy [3][4] - The launch of Brenzavvy establishes a new model for next-generation drugs that offer specific advantages over established market leaders [4] Market Context - A significant gap exists in the prescription of SGLT-2 inhibitors, with only 11.9% of eligible diabetic patients receiving guideline-recommended prescriptions, indicating a need for improved care [2] - The launch of Brenzavvy is positioned to address the high out-of-pocket costs faced by many patients, particularly those who are uninsured or underinsured [4]

Core Viewpoint - Wellgistics Health, Inc. has announced a record date of December 19, 2025, for shareholders to receive the Dream Bowl 2026 Meme Coin, with one coin distributed for each share owned [1] Company Overview - Wellgistics Health, Inc. is a leader in health information technology, focusing on the implementation of EinsteinRx™ artificial intelligence for prescription drug routing [1] - The company utilizes a blockchain-enabled smart contracts platform, PharmacyChain™, to enhance the reimbursement and dispensing process for prescription medicines [1]

Group 1 - The company plans to distribute Dream Bowl 2026 Meme Coin to shareholders with a record date and distribution date expected in December 2025 [1] - Distribution of the Meme Coin is anticipated to occur in January 2026 [1] - Wellgistics Health, Inc. is involved in the DataVault AI Shareholder Distribution Plan and is sponsoring Dream Bowl 2026 [1] Group 2 - Wellgistics is a leader in health information technology, utilizing EinsteinRx™ artificial intelligence for prescription routing [1] - The company employs PharmacyChain™ blockchain-enabled smart contracts to enhance the tracking and dispensing of prescription drugs [1] - The technology aims to optimize insurance coverage from manufacturers to patients [1]

Core Insights - Wellgistics is positioned to lead in the Web 3.0 Health Information Data Transfer within the $634 billion prescription drug industry through an exclusive licensing agreement with Datavault AI [1][2][6] - The implementation of Wellgistics' EinsteinRx AI hub is expected to optimize automated prescription fulfillment for various stakeholders including manufacturers, pharmacies, and patients [1][4][6] - Datavault's intellectual property enables smart contracts that create a barrier to entry in the $4.9 trillion US healthcare market [1][2] Company Overview - Wellgistics Health, based in Tampa, Florida, specializes in optimizing medication delivery from manufacturers to patients, connecting over 6,500 pharmacies and 200 manufacturers [3][9] - The PharmacyChain initiative aims to digitize the tracking of prescription drugs, ensuring accurate delivery and recommendations for safe use [3][5] Technology and Innovation - The completion of the EinsteinRx AI hub integrates Wellgistics' IT and physical infrastructure, enhancing the efficiency of prescription fulfillment and reducing costs associated with pharmacy benefits managers (PBMs) [4][5][6] - Wellgistics aims to minimize or eliminate PBM rebates, thereby reducing administrative burdens for payers and improving the overall pharmaceutical distribution process [6][7] Market Potential - PwC estimates a $1 trillion opportunity to shift healthcare spending towards a digital-first, proactive, and personalized system [2] - The integration of smart contracts into Wellgistics' operations is expected to significantly improve cost efficiency in the prescription filling process, benefiting various stakeholders in the healthcare ecosystem [6][7]

Financial Results - Wellgistics Health, Inc. reported financial results for the quarter ended September 30, 2025, with a press release issued on November 20, 2025[5]. - The press release includes forward-looking statements regarding the company's projects and potential financial performance[9]. - The press release is attached as Exhibit 99.1, which contains detailed financial results and operational insights[11]. Company Classification and Regulations - The company is classified as an emerging growth company under the Securities Act of 1933[4]. - The company’s Registration Statement on Form S-1 was declared effective by the SEC on September 25, 2025, discussing various risks associated with forward-looking statements[9]. Financial Metrics and Guidance - The company has not yet disclosed specific financial metrics or performance indicators in the provided documents[5]. - The company has not provided specific guidance or outlook for future performance in the available documents[5]. Company Information - The company’s principal executive offices are located in Tampa, FL[1]. - The trading symbol for Wellgistics Health, Inc. is WGRX, listed on The Nasdaq Capital Market LLC[3]. Product and Market Information - The report does not include any information on new products, technologies, market expansion, or acquisitions[5].